ELLIGO HEALTH RESEARCH, INC.
AUSTIN, TX

Founded in Austin, Texas on March 15, 2017, Elligo Health Research, Inc. is a pioneering clinical research infrastructure (CRI) provider that aims to enhance clinical trial access and efficiency by engaging the often inaccessible 97 percent of physicians and patients who do not participate in clinical research. The company strategically leverages electronic health records and innovative informatics to match real-world patients with suitable clinical studies at their respective clinics, offering both technologies and operational support for seamless study execution. Elligo's mission centers on enabling broader participation in clinical trials through the integration of healthcare informatics into routine practice, thereby accelerating the development and approval processes of new medical therapies. Their approach not only reduces barriers to physician and patient involvement but also helps research sponsors achieve enrollment targets more swiftly with high-quality referrals. The company's leadership includes John Potthoff as CEO, alongside directors Christian Lange and John Crumpler. Elligo serves a unique role in the healthcare sector by unifying clinical data analytics capabilities with ground-level health care delivery, as evidenced by collaborations such as their partnership with Saama Data Inc., enhancing data aggregation for clinical studies. Elligo Health Research's commitment to improving healthcare outcomes extends beyond its technological solutions; it fosters an environment where industry professionals can thrive and contribute significantly to advancements in treatment availability. With over 4,000 research sites across more than 45 countries under its influence, Elligo's impact on the global clinical community is profound. For further details about their initiatives or to discuss potential collaborations, interested parties are encouraged to visit their website at [elligohealthresearch.com](http://www.elligohealthresearch.com). As evidenced by their operational strategies and market engagements, Elligo Health Research remains dedicated to its goal of bridging the gap between clinical research and healthcare delivery globally.